Bazedoxifene/conjugated estrogens

Bazedoxifene/conjugated estrogens, sold under the brand name Duavee in the US and Duavive in the EU, is a fixed-dose combination medication for the treatment of menopause symptoms and postmenopausal osteoporosis.[2] It contains the selective estrogen receptor modulator bazedoxifene and conjugated estrogens. It is taken by mouth.

Bazedoxifene/conjugated estrogens
Combination of
BazedoxifeneSelective estrogen receptor modulator
Conjugated estrogensEstrogen
Clinical data
Trade namesDuavee, Duavive
AHFS/Drugs.comProfessional Drug Facts
MedlinePlusa614004
License data
Pregnancy
category
    Routes of
    administration
    By mouth
    ATC code
    Legal status
    Legal status
    • US: ℞-only
    • In general: ℞ (Prescription only)
    Identifiers
    ChemSpider
    • None
    KEGG

    The combination was approved for medical use in the United States in October 2013,[3] and in the European Union in December 2014.[4]

    Recall

    In June 2020, Pfizer recalled recalled two batches of Duavive, its oestrogen replacement product, as a result of concerns raised about faulty packaging.[5]

    gollark: Why should you do this?
    gollark: Oh, of course, osmarkscalculator rather than osmarkscalculator™.
    gollark: It's more of a horrific tree rewriter engine™ than programming language.
    gollark: I didn't think it used a stack.
    gollark: What are you using "Rust" for anyway? osmarkscalculator™ contributions?

    See also

    References


    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.